Centers for Disease Control and Prevention. (2022). Streptococcus pneumoniae. Retrieved from https://www.cdc.gov/pneumococcal/clinicians/streptococcus-pneumoniae.html#:~:text=There%20are%20100%20known%20serotypes,more%20than%20100%20known%20serotypes

Backhaus, E., Berg, S., Andersson, R., Ockborn, G., Malmstrom, P., Dahl, M., Nasic, S., & Trollfors, B. (2016). Epidemiology of invasive pneumococcal infections: Manifestations, incidence and case fatality rate correlated to age, gender and risk factors. BMC Infectious Diseases, 16, 367. https://doi.org/10.1186/s12879-016-1648-2

Article  PubMed  PubMed Central  Google Scholar 

Berical, A. C., Harris, D., Dela Cruz, C. S., & Possick, J. D. (2016). Pneumococcal vaccination strategies. An update and perspective. Annals of the American Thoracic Society, 13(6), 933–944. https://doi.org/10.1513/AnnalsATS.201511-778FR

Article  PubMed  PubMed Central  Google Scholar 

Ceyhan, M., Ozsurekci, Y., Aykac, K., Hacibedel, B., & Ozbilgili, E. (2018). Economic burden of pneumococcal infections in children under 5 years of age. Human Vaccines & Immunotherapeutics, 14(1), 106–110. https://doi.org/10.1080/21645515.2017.1371378

Article  Google Scholar 

de Benedictis, F. M., Kerem, E., Chang, A. B., Colin, A. A., Zar, H. J., & Bush, A. (2020). Complicated pneumonia in children. Lancet, 396(10253), 786–798. https://doi.org/10.1016/S0140-6736(20)31550-6

Article  PubMed  Google Scholar 

Poehling, K. A., Talbot, T. R., Griffin, M. R., Craig, A. S., Whitney, C. G., Zell, E., Lexau, C. A., Thomas, A. R., Harrison, L. H., Reingold, A. L., Hadler, J. L., Farley, M. M., Anderson, B. J., & Schaffner, W. (2006). Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA, 295(14), 1668–1674. https://doi.org/10.1001/jama.295.14.1668

Article  CAS  PubMed  Google Scholar 

Thadchanamoorthy, V., & Dayasiri, K. (2021). Review on pneumococcal infection in children. Cureus, 13(5), e14913. https://doi.org/10.7759/cureus.14913

Article  PubMed  PubMed Central  Google Scholar 

Thorrington, D., Andrews, N., Stowe, J., Miller, E., & van Hoek, A. J. (2018). Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite control. BMC Medicine, 16(1), 13. https://doi.org/10.1186/s12916-018-1004-z

Article  PubMed  PubMed Central  Google Scholar 

Thorrington, D., van Rossum, L., Knol, M., de Melker, H., Rumke, H., Hak, E., & van Hoek, A. J. (2018). Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands. PLoS ONE, 13(2), e0192640. https://doi.org/10.1371/journal.pone.0192640

Article  CAS  PubMed  PubMed Central  Google Scholar 

Advisory Committee on Immunization Practices. (2023). AACIP updates: Recommendations for use of 20-valent pneumococcal conjugate vaccine in children - United States, 2023. MMWR. Morbidity and Mortality Weekly Report. https://doi.org/10.15585/mmwr.mm7239a5

Article  Google Scholar 

European Medicines Agency. (2024). Vaxneuvance - pneumococcal polysaccharide conjugate vaccine (adsorbed). Retrieved from https://www.ema.europa.eu/en/medicines/human/EPAR/vaxneuvance

Kobayashi, M., Farrar, J. L., Gierke, R., Britton, A., Childs, L., Leidner, A. J., Campos-Outcalt, D., Morgan, R. L., Long, S. S., Talbot, H. K., Poehling, K. A., & Pilishvili, T. (2022). Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. adults: Updated recommendations of the advisory committee on immunization practices - United States, 2022. MMWR Morbidity and Mortality Weekly Report, 71(4), 109–117. https://doi.org/10.15585/mmwr.mm7104a1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brazier, J., Ratcliffe, J., Saloman, J., & Tsuchiya, A. (2017). Measuring and valuing health benefits for economic evaluation (2nd ed.). Oxford University Press.

Google Scholar 

O’Reilly, R., Yokoyama, S., Boyle, J., Kwong, J. C., McGeer, A., To, T., & Sander, B. (2022). The impact of acute pneumococcal disease on health state utility values: A systematic review. Quality of Life Research, 31(2), 375–388. https://doi.org/10.1007/s11136-021-02941-y

Article  PubMed  Google Scholar 

Tang, Z., Matanock, A., Jeon, S., & Leidner, A. J. (2022). A review of health-related quality of life associated with pneumococcal disease: Pooled estimates by age and type of disease. Journal of Public Health (Oxford, England), 44(2), e234–e240. https://doi.org/10.1093/pubmed/fdab159

Article  PubMed  Google Scholar 

Oh, P. I., Maerov, P., Pritchard, D., Knowles, S. R., Einarson, T. R., & Shear, N. H. (1996). A cost-utility analysis of second-line antibiotics in the treatment of acute otitis media in children. Clinical Therapeutics, 18(1), 160–182. https://doi.org/10.1016/s0149-2918(96)80188-3

Article  CAS  PubMed  Google Scholar 

Kulpeng, W., Sornsrivichai, V., Chongsuvivatwong, V., Rattanavipapong, W., Leelahavarong, P., Cairns, J., Lubell, Y., & Teerawattananon, Y. (2013). Variation of health-related quality of life assessed by caregivers and patients affected by severe childhood infections. BMC Pediatrics, 13, 122. https://doi.org/10.1186/1471-2431-13-122

Article  PubMed  PubMed Central  Google Scholar 

Petrou, S., Dakin, H., Abangma, G., Benge, S., & Williamson, I. (2010). Cost-utility analysis of topical intranasal steroids for otitis media with effusion based on evidence from the GNOME trial. Value in Health, 13(5), 543–551. https://doi.org/10.1111/j.1524-4733.2010.00711.x

Article  PubMed  Google Scholar 

Bennett, J. E., Sumner, W., 2nd., Downs, S. M., & Jaffe, D. M. (2000). Parents’ utilities for outcomes of occult bacteremia. Archives of Pediatrics & Adolescent Medicine, 154(1), 43–48.

CAS  Google Scholar 

Crawford, B., Hashim, S. S., Prepageran, N., See, G. B., Meier, G., Wada, K., Coon, C., Delgleize, E., & DeRosa, M. (2017). Impact of pediatric acute otitis media on child and parental quality of life and associated productivity loss in Malaysia: A prospective observational study. Drugs Real World Outcomes, 4(1), 21–31. https://doi.org/10.1007/s40801-016-0099-9

Article  PubMed  Google Scholar 

Verstraete, J., Ramma, L., & Jelsma, J. (2020). Validity and reliability testing of the Toddler and Infant (TANDI) health related quality of life instrument for very young children. Journal of Patient-Reported Outcomes, 4(1), 94. https://doi.org/10.1186/s41687-020-00251-4

Article  PubMed  PubMed Central  Google Scholar 

Furlong, W., Rae, C., Feeny, D., Ghotra, S., Breakey, V. R., Carter, T., Pai, N., Pullenayegum, E., Xie, F., & Barr, R. (2023). Generic health-related quality of life utility measure for preschool children (health utilities preschool): Design, development, and properties. Value in Health, 26(2), 251–260. https://doi.org/10.1016/j.jval.2022.07.015

Article  PubMed  Google Scholar 

Matza, L. S., Stewart, K. D., Lloyd, A. J., Rowen, D., & Brazier, J. E. (2021). Vignette-based utilities: Usefulness, limitations, and methodological recommendations. Value in Health, 24(6), 812–821. https://doi.org/10.1016/j.jval.2020.12.017

Article  PubMed  Google Scholar 

Boye, K. S., Matza, L. S., Feeny, D. H., Johnston, J. A., Bowman, L., & Jordan, J. B. (2014). Challenges to time trade-off utility assessment methods: When should you consider alternative approaches? Expert Review of Pharmacoeconomics & Outcomes Research, 14(3), 437–450. https://doi.org/10.1586/14737167.2014.912562

Article  Google Scholar 

Matza, L. S., Kim, K. J., Yu, H., Belden, K. A., Chen, A. F., Kurd, M., Lee, B. Y., & Webb, J. (2019). Health state utilities associated with post-surgical Staphylococcus aureus infections. The European Journal of Health Economics, 20(6), 819–827. https://doi.org/10.1007/s10198-019-01036-3

Article  PubMed  PubMed Central  Google Scholar 

Devlin, N., Pan, T., Kreimeier, S., Verstraete, J., Stolk, E., Rand, K., & Herdman, M. (2022). Valuing EQ-5D-Y: The current state of play. Health and Quality of Life Outcomes, 20(1), 105. https://doi.org/10.1186/s12955-022-01998-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kreimeier, S., Oppe, M., Ramos-Goni, J. M., Cole, A., Devlin, N., Herdman, M., Mulhern, B., Shah, K. K., Stolk, E., Rivero-Arias, O., & Greiner, W. (2018). Valuation of EuroQol five-dimensional questionnaire, youth version (EQ-5D-Y) and EuroQol five-dimensional questionnaire, three-level version (EQ-5D-3L) health states: The impact of wording and perspective. Value in Health, 21(11), 1291–1298. https://doi.org/10.1016/j.jval.2018.05.002

Article  PubMed  Google Scholar 

Kwon, J., Freijser, L., Huynh, E., Howell, M., Chen, G., Khan, K., Daher, S., Roberts, N., Harrison, C., Smith, S., Devlin, N., Howard, K., Lancsar, E., Bailey, C., Craig, J., Dalziel, K., Hayes, A., Mulhern, B., Wong, G., Ratcliffe, J., & Petrou, S. (2022). Systematic review of conceptual, age, measurement and valuation considerations for generic multidimensional childhood patient-reported outcome measures. Pharmacoeconomics, 40(4), 379–431. https://doi.org/10.1007/s40273-021-01128-0

Article  PubMed  PubMed Central  Google Scholar 

Prosser, L. A., Hammitt, J. K., & Keren, R. (2007). Measuring health preferences for use in cost-utility and cost-benefit analyses of interventions in children: Theoretical and methodological considerations. PharmacoEconomics, 25(9), 713–726. https://doi.org/10.2165/00019053-200725090-00001

Article  PubMed  Google Scholar